The amplification and activation of EGFR, platelet derived growth factor receptor α (PDGFRα), and mesenchymal-epithelial transition factor (MET) are the top three desregulated RTKs, which promote the proliferation and invasion of glioma cells [29]. This evidence concerns the gene EGFR and central nervous system cancer.